Owners, management and financials
CVR: 42443670
Secondary names: Patentselskabet af 31. maj 2021 ApS
Previous names: Patentselskabet af 31. maj 2021 ApS.
DKK -13,719,778
Gross profit
Net result: DKK -13,943,884
LUNDBECKFOND INVEST A/S (33,33-49,99%), Helms & Sams ApS (5-9,99%)
3 more
CVR · view owners
Mark Stephen Sumeray
Board: Anders Gaarsdal Holst (chair) and 3 members
CVR · view management
Active
Founded 4 June 2021
CVR · view overview
5 employees
CVR · 2026
Owner registered: LUNDBECKFOND INVEST A/S
CVR · 28/08/2026
View the full event history
Epoqe Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Patentselskabet af 31. maj 2021 ApS.. The management consists of Mark Stephen Sumeray. The board consists of Anders Gaarsdal Holst (chair), Henrijette Elsebeth Richter, Lars Gredsted and Mark Stephen Sumeray. The company's owners include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity in the 2025 report amounted to DKK 30,042,156.
Selskabets formål er at udvikle og markedsføre et eller flere lægemidler, herunder at drive forskning med henblik på at identificere, validere, udvikle og markedsføre lægemidler tillige med anden virksomhed, der står i forbindelse hermed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | -13.7M | -13.9M | 34.9M | 30M | 3 | |
| 202401/07/2023 – 30/06/2024 | 1.3M | -136K | 1.1M | -18K | 2 | |
| 202301/07/2022 – 30/06/2023 | -19K | -15K | 2.6M | 118K | - | |
| 202204/06/2021 – 30/06/2022 | -17K | -18K | 145K | 133K | - |
Compared to 1.037 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of Epoqe Pharma ApS is 42443670.
The owners of Epoqe Pharma ApS include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS.
The management of Epoqe Pharma ApS consists of Mark Stephen Sumeray.
The board of Epoqe Pharma ApS consists of Anders Gaarsdal Holst, Henrijette Elsebeth Richter and Lars Gredsted, with Anders Gaarsdal Holst as chair.
In 2025, Epoqe Pharma ApS reported a gross profit of DKK -13,719,778.
Epoqe Pharma ApS had 5 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (September 24, 2026).
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (September 15, 2026).
As of August 28, 2026, LUNDBECKFOND INVEST A/S is registered as an owner of Epoqe Pharma ApS with an ownership share of 33%.
As of August 28, 2026, Helms & Sams ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.
As of August 28, 2026, CMCGreenhouse ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.
As of August 28, 2026, is registered as an owner of Epoqe Pharma ApS with an ownership share of 33%.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 23, 2026).
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 22, 2026).
As of June 22, 2026, Mark Stephen Sumeray has joined the board of directors of Epoqe Pharma ApS.
As of June 22, 2026, Anette Sams Nielsen has left the board of directors of Epoqe Pharma ApS.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 9, 2026).
As of June 2, 2026, Mark Stephen Sumeray is registered as adm. dir. of Epoqe Pharma ApS.
As of June 2, 2026, Anette Sams Nielsen has stepped down as adm. dir. of Epoqe Pharma ApS.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (April 28, 2026).
Epoqe Pharma ApS has published its interim report for the period July 1, 2025 to December 31, 2025.
Epoqe Pharma ApS has published its annual report for 2025. Gross profit came to DKK -13,719,778, and the net result was DKK -13,943,884.
As of July 31, 2025, Jens Thostrup Bukrinski has stepped down as director of Epoqe Pharma ApS.
As of January 9, 2025, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Lars Gredsted has joined the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Anders Gaarsdal Holst has left the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Henrijette Elsebeth Richter has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Anette Sams Nielsen has joined the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Jan Bjerrum Bach has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Alejandra Maria Cristina Bonifacini Mørk has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Edvince ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.
Epoqe Pharma ApS has published its annual report for 2024. Gross profit came to DKK 1,273,171, and the net result was DKK -135,919.
Epoqe Pharma ApS has published its annual report for 2023. Gross profit came to DKK -19,351, and the net result was DKK -15,427.
As of October 12, 2023, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Jan Bjerrum Bach has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Epoqe Pharma ApS.
Epoqe Pharma ApS has published its annual report for 2022. Gross profit came to DKK -17,070, and the net result was DKK -18,026.
As of December 14, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Epoqe Pharma ApS.
As of December 14, 2021, Anette Sams Nielsen is registered as adm. dir. of Epoqe Pharma ApS.
As of December 14, 2021, Jens Thostrup Bukrinski is registered as director of Epoqe Pharma ApS.
On December 14, 2021, the company changed its name from Patentselskabet af 31. maj 2021 ApS. to Epoqe Pharma ApS.
As of December 13, 2021, Anette Sams Nielsen has stepped down as director of Epoqe Pharma ApS.
As of June 4, 2021, Anette Sams Nielsen is registered as director of Epoqe Pharma ApS.
Epoqe Pharma ApS was founded on June 4, 2021.
Companies in the same industry and area
CVR 40766383
CVR 42597333
CVR 46613139
CVR 44504332
CVR 43917897
